CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to INCY

parsaclisib + itacitinib

Phase 2
Incyte Corporation (INCY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '26
INCYPhase 2

parsaclisib + itacitinib Phase 2 Est. Readout

parsaclisib + itacitinib
Nov 2026~STALE
CT.gov
00%
Competitive Landscape

1 competitor in B-Cell Malignancies

View Full Landscape
Drug Information

Target Indication

B-Cell Malignancies

Clinical Trial

NCT04509700

Last updated: 12/5/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.